BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23188130)

  • 1. Cardioankle vascular index evaluations revealed that cotreatment of ARB Antihypertension medication with traditional Chinese medicine improved arterial functionality.
    Xu Y; Yan H; Yao MJ; Ma J; Jia JM; Ruan FX; Yao ZC; Huang HM; Zheng J; Chen T; Lv H; Endler AM
    J Cardiovasc Pharmacol; 2013 May; 61(5):355-60. PubMed ID: 23188130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
    Ichihara A; Kaneshiro Y; Sakoda M; Takemitsu T; Itoh H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):161-6. PubMed ID: 17414228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA; Sfakianakis ME; Tsourous GI; Georgiopoulos DX; Fragouli EG; Katsanou PM; Tavoularis EI; Skarlatou MG; Marakomichelakis GE; Ifanti GK; Diamantopoulos EJ
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
    Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.
    Ono H; Minatoguchi S; Watanabe K; Yamada Y; Mizukusa T; Kawasaki H; Takahashi H; Uno T; Tsukamoto T; Hiei K; Fujiwara H
    Hypertens Res; 2008 Feb; 31(2):271-9. PubMed ID: 18360047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension.
    Agata J; Nagahara D; Kinoshita S; Takagawa Y; Moniwa N; Yoshida D; Ura N; Shimamoto K
    Circ J; 2004 Dec; 68(12):1194-8. PubMed ID: 15564706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension.
    Sasamura H; Kitamura Y; Nakamura M; Ryuzaki M; Saruta T
    Clin Exp Hypertens; 2006 Jul; 28(5):511-20. PubMed ID: 16820347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.
    Han SH; Kang EW; Yoon SJ; Yoon HS; Lee HC; Yoo TH; Choi KH; Han DS; Kang SW
    Nephrol Dial Transplant; 2011 Nov; 26(11):3722-8. PubMed ID: 21385862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients' quality of life: the Saga Challenge Antihypertensive Study (S-CATS).
    Kamura A; Inoue T; Kuroki S; Ishida S; Iimori K; Kato T; Naitoh H; Tamesue S; Ikeda H; Node K
    Hypertens Res; 2011 Dec; 34(12):1288-94. PubMed ID: 21814213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Chinese herbal medicine for calming Gan (肝) and suppressing hyperactive yang on arterial elasticity function and circadian rhythm of blood pressure in patients with essential hypertension.
    Zhong GW; Chen MJ; Luo YH; Xiang LL; Xie QY; Li YH; Zhang C; Gao F
    Chin J Integr Med; 2011 Jun; 17(6):414-20. PubMed ID: 21660675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
    Kasanuki H; Hagiwara N; Hosoda S; Sumiyoshi T; Honda T; Haze K; Nagashima M; Yamaguchi J; Origasa H; Urashima M; Ogawa H;
    Eur Heart J; 2009 May; 30(10):1203-12. PubMed ID: 19346521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on medical pattern of traditional Chinese medicine and western medicine diagnosis and treatment of hypertension patients in 30 034 cases in real world].
    Ma JH; Wang ZF; Xie YM; Yang W; Yang ZX; Zhuang Y; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3435-41. PubMed ID: 25532374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor blockade in the challenging era of systolic hypertension.
    Stergiou GS
    J Hum Hypertens; 2004 Dec; 18(12):837-47. PubMed ID: 15318161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
    Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.